Egle Jurgaityte is a Senior Research Associate in the Therapeutics/Development group focused on developing new cell therapies against our novel targets. Prior to joining Cartography, she was an undergraduate researcher at DuPage/Raulet labs at the University of California, Berkeley. Egle holds a B.A. in Molecular and Cell Biology from UC Berkeley. In her spare time, she enjoys surfing, hiking, and exploring new places.
Recent Posts
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
- Cartography Biosciences Co-Founder and Chief Executive Officer Kevin Parker, Ph.D., Earns Spot on Endpoints News’ 20 Under 40 List
Recent Comments
No comments to show.